Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 3
1971 2
1973 2
1974 2
1975 1
1976 4
1977 2
1978 7
1980 8
1981 3
1984 4
1985 5
1986 3
1987 4
1988 6
1989 7
1990 4
1991 4
1992 7
1993 3
1994 9
1995 6
1996 7
1997 4
1998 3
1999 4
2000 4
2001 3
2002 6
2003 2
2004 2
2005 6
2006 6
2007 10
2008 10
2009 6
2010 7
2011 4
2012 2
2013 7
2014 2
2015 5
2016 3
2017 4
2018 4
2019 5
2020 3
2021 4
2022 3
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
IP6K2 predicts favorable clinical outcome of primary breast cancer.
Sandström J, Balian A, Lockowandt R, Fornander T, Nordenskjöld B, Lindström L, Pérez-Tenorio G, Stål O. Sandström J, et al. Among authors: nordenskjold b. Mol Clin Oncol. 2021 May;14(5):94. doi: 10.3892/mco.2021.2256. Epub 2021 Mar 12. Mol Clin Oncol. 2021. PMID: 33767863 Free PMC article.
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
Yu NY, Iftimi A, Yau C, Tobin NP, van 't Veer L, Hoadley KA, Benz CC, Nordenskjöld B, Fornander T, Stål O, Czene K, Esserman LJ, Lindström LS. Yu NY, et al. Among authors: nordenskjold b. JAMA Oncol. 2019 Sep 1;5(9):1304-1309. doi: 10.1001/jamaoncol.2019.1856. JAMA Oncol. 2019. PMID: 31393518 Free PMC article.
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Johansson A, Yu NY, Iftimi A, Tobin NP, van 't Veer L, Nordenskjöld B, Benz CC, Fornander T, Perez-Tenorio G, Stål O, Esserman LJ, Yau C, Lindström LS. Johansson A, et al. Among authors: nordenskjold b. Int J Cancer. 2022 Jun 15;150(12):2072-2082. doi: 10.1002/ijc.33969. Epub 2022 Mar 7. Int J Cancer. 2022. PMID: 35179782 Free PMC article.
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
Johansson A, Dar H, van 't Veer LJ, Tobin NP, Perez-Tenorio G, Nordenskjöld A, Johansson U, Hartman J, Skoog L, Yau C, Benz CC, Esserman LJ, Stål O, Nordenskjöld B, Fornander T, Lindström LS. Johansson A, et al. Among authors: nordenskjold b. J Clin Oncol. 2022 Dec 10;40(35):4071-4082. doi: 10.1200/JCO.21.02844. Epub 2022 Jul 21. J Clin Oncol. 2022. PMID: 35862873 Free article. Clinical Trial.
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group. Lindström LS, et al. Among authors: nordenskjold b. J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270. J Natl Cancer Inst. 2018. PMID: 29361175 Free PMC article.
Soft tissue sarcoma and occupational exposures.
Wingren G, Fredrikson M, Brage HN, Nordenskjöld B, Axelson O. Wingren G, et al. Among authors: nordenskjold b. Cancer. 1990 Aug 15;66(4):806-11. doi: 10.1002/1097-0142(19900815)66:4<806::aid-cncr2820660435>3.0.co;2-u. Cancer. 1990. PMID: 2386907
215 results